first
identifi
patient
sampl
wuhan
china
human
airway
epitheli
cell
cultur
viru
bal
fluid
isol
patient
supernat
collect
cell
damag
kill
analyz
negativestain
transmiss
electron
microscopi
figur
imag
reveal
viru
diamet
rang
nm
envelop
protein
spike
genet
overal
structur
look
similar
virus
coronavirida
famili
singlestrand
posit
sens
rna
genom
nucleotid
genom
encod
protein
includ
rnadepend
rna
polymeras
rdrp
four
structur
act
conjunct
nonstructur
protein
maintain
genom
fidel
region
rdrp
gene
shown
highli
similar
region
rdrp
gene
found
bat
coronaviru
similar
overal
genom
strain
sequenc
decemb
midfebruari
sequenc
homolog
observ
recent
chang
viral
genom
catalogu
show
higher
sequenc
four
structur
protein
includ
spike
surfac
glycoprotein
small
envelop
protein
e
matrix
protein
nucleocapsid
protein
n
coronavirus
gene
code
receptorbind
spike
protein
enabl
viru
infect
spike
protein
mediat
receptor
bind
membran
fusion
determin
host
tropism
transmiss
gene
diverg
nucleotid
sequenc
similar
compar
previous
describ
sarsrel
three
structur
protein
conserv
spike
protein
necessari
gener
coronaviru
protein
involv
encas
rna
andor
protein
assembl
bud
envelop
format
appear
interact
angiotensin
convert
enzym
receptor
entri
cell
zhou
et
al
conduct
infect
studi
incub
hela
cell
differenti
receptor
author
show
coloc
fluoresc
stain
virus
cell
express
receptor
chines
horsesho
bat
pig
human
civet
mice
mrna
present
almost
human
organ
present
arteri
venou
endotheli
cell
arteri
smooth
muscl
cell
lung
stomach
small
intestin
colon
skin
lymph
node
liver
bile
duct
kidney
pariet
epitheli
cell
brain
also
express
surfac
lung
alveolar
epitheli
cell
enterocyt
small
intestin
allow
infect
tissu
upper
respiratori
tract
ie
oral
nasal
mucosa
nasopharynx
show
surfac
express
epitheli
cell
therefor
unlik
primari
site
ct
scan
may
show
higher
opac
lower
lung
cell
region
express
isol
oral
swab
bal
fluid
higher
viral
load
record
nose
versu
throat
similar
viral
load
seen
asymptomat
symptomat
understand
biolog
properti
enabl
research
develop
diagnost
detect
symptom
express
patient
nonspecif
use
accur
diagnosi
guan
et
al
report
patient
china
fever
enter
hospit
develop
fever
found
patient
cough
fatigu
sputum
product
short
breath
mani
symptom
could
associ
respiratori
infect
nucleic
acid
test
ct
scan
use
diagnos
screen
molecular
techniqu
suitabl
syndrom
test
ct
scan
accur
diagnos
target
identifi
specif
pathogen
develop
molecular
techniqu
depend
upon
understand
proteom
genom
composit
pathogen
induct
chang
express
proteinsgen
host
infect
march
genom
proteom
composit
identifi
host
respons
viru
still
investig
first
genom
sequenc
conduct
metagenom
rna
sequenc
unbias
highthroughput
method
sequenc
multipl
find
publicli
disclos
sequenc
ad
genbank
sequenc
repositori
januari
sinc
sequenc
made
avail
global
initi
share
influenza
data
gisaid
genbank
research
across
accord
joint
report
world
health
organ
china
strain
viru
isol
sequenc
use
illumina
oxford
nanopor
sequenc
end
decemb
midfebruari
illumina
sequenc
sequencebysynthesi
method
use
solidphas
bridg
amplif
wherera
nanopor
sequenc
involv
transloc
dna
molecul
protein
pore
measur
subsequ
shift
voltag
determin
dna
genom
sequenc
import
research
design
primer
probe
sequenc
pcr
nucleic
acid
test
nucleic
acid
test
primari
method
diagnos
number
revers
transcript
polymeras
chain
reaction
rtpcr
kit
design
detect
genet
tabl
rtpcr
involv
revers
transcript
rna
complementari
dna
cdna
strand
follow
amplif
specif
region
design
process
gener
involv
two
main
step
sequenc
align
primer
design
assay
optim
test
corman
et
al
align
analyz
number
sarsrel
viral
genom
sequenc
design
set
primer
among
sarsrel
viral
genom
discov
three
region
conserv
sequenc
rdrp
gene
rnadepend
rna
polymeras
gene
open
read
frame
region
e
gene
envelop
protein
gene
n
gene
nucleocapsid
protein
gene
rdrp
e
gene
high
analyt
sensit
detect
technic
limit
detect
copi
per
reaction
wherea
n
gene
provid
poorer
analyt
sensit
copi
per
reaction
assay
design
twotarget
system
one
primer
univers
detect
numer
coronavirus
includ
second
primer
set
detect
design
primer
probe
next
step
involv
optim
assay
condit
eg
reagent
condit
incub
time
temperatur
follow
pcr
test
rtpcr
perform
either
onestep
twostep
assay
onestep
assay
revers
transcript
pcr
amplif
consolid
one
reaction
assay
format
provid
rapid
reproduc
result
highthroughput
analysi
challeng
difficulti
optim
revers
transcript
amplif
step
occur
simultan
lead
lower
target
amplicon
gener
twostep
assay
reaction
done
sequenti
separ
assay
format
sensit
onestep
assay
timeconsum
requir
optim
addit
lastli
control
need
care
select
ensur
reliabl
assay
identifi
experiment
error
least
nucleicacidbas
method
eight
antibodi
detect
kit
approv
china
nation
medic
product
administr
nmpa
detect
howev
rtpcr
predominantli
use
method
diagnos
use
respiratori
upper
respiratori
sampl
broadli
recommend
although
lower
respiratori
sampl
recommend
patient
exhibit
product
upper
respiratori
tract
sampl
includ
nasopharyng
swab
oropharyng
swab
nasopharyng
wash
nasal
aspir
lower
respiratori
tract
sampl
includ
sputum
bal
fluid
tracheal
aspir
bal
tracheal
aspir
high
risk
aerosol
gener
detect
viral
load
depend
day
ill
onset
first
day
onset
could
reliabl
detect
sputum
follow
nasal
swab
wherea
throat
swab
unreli
day
symptom
given
variabl
viral
load
neg
test
result
respiratori
sampl
rule
diseas
neg
could
result
improp
sampl
techniqu
low
viral
load
area
sampl
mutat
viral
winichakoon
et
al
recommend
multipl
line
evid
patient
link
epidemiolog
even
result
neg
nasopharyng
andor
oropharyng
unit
state
center
diseas
control
prevent
cdc
use
onestep
real
time
rtpcr
rrtpcr
assay
provid
quantit
inform
viral
load
detect
presenc
perform
assay
viral
rna
extract
ad
master
mix
master
mix
contain
nucleasefre
water
forward
revers
primer
fluorophorequench
probe
reaction
mix
consist
revers
transcriptas
polymeras
magnesium
nucleotid
addit
master
mix
extract
rna
load
pcr
thermocycl
incub
temperatur
set
run
assay
cdc
recommend
cycl
condit
rrtpcr
fluorophorequench
probe
cleav
gener
fluoresc
signal
fluoresc
signal
detect
thermocycl
amplif
progress
record
real
time
probe
sequenc
use
guan
et
al
black
hole
quencher
fluorescein
amidit
fam
fluorophor
reaction
take
min
occur
plate
well
contain
differ
sampl
control
must
posit
neg
control
interpret
final
result
properli
run
rrtpcr
cdc
provid
posit
control
sequenc
call
number
rtpcr
primer
probe
differ
research
group
agenc
list
tabl
differ
implement
workflow
rtpcr
test
clinic
set
corman
et
al
propos
threestep
workflow
diagnosi
defin
three
step
first
line
screen
confirm
discriminatori
assay
maxim
number
infect
patient
identifi
first
step
detect
sarsrel
virus
target
differ
region
e
gene
test
posit
propos
detect
rdrp
gene
use
two
differ
primer
two
differ
probe
result
also
posit
conduct
discriminatori
test
one
two
probe
see
tabl
germani
chu
et
al
propos
slightli
differ
assay
screen
sampl
use
primer
n
gene
use
orflb
gene
confirm
diagnosi
patient
sampl
posit
n
gene
primer
neg
orflb
gene
would
inconclus
situat
protein
test
ie
antibodi
test
sequenc
would
requir
confirm
due
shortag
kit
fals
neg
rate
rtpcr
hubei
provinc
china
temporarili
use
ct
scan
clinic
diagnosi
chest
ct
scan
noninvas
involv
take
mani
xray
measur
differ
angl
across
patient
chest
produc
crosssect
imag
analyz
radiologist
look
abnorm
featur
lead
imag
featur
divers
depend
stage
infect
onset
symptom
exampl
bernheim
et
al
saw
frequent
normal
ct
find
earli
stage
diseas
day
maximum
lung
involv
peak
around
day
onset
common
hallmark
featur
includ
bilater
peripher
groundglass
opac
area
hazi
opac
consolid
lung
fluid
solid
materi
compress
lung
tissu
de
wever
et
al
found
groundglass
opac
promin
day
symptom
onset
infect
progress
addit
groundglass
opac
crazypav
pattern
ie
irregularshap
pave
stone
pattern
follow
increas
consolid
base
imag
featur
sever
retrospect
studi
shown
ct
scan
higher
sensit
improv
fals
neg
rate
compar
main
caveat
use
ct
specif
low
imag
featur
overlap
viral
current
diagnos
rtpcr
screen
ct
scan
techniqu
drawback
three
issu
arisen
rtpcr
first
avail
pcr
reagent
kit
kept
demand
second
commun
hospit
outsid
urban
citi
lack
pcr
infrastructur
accommod
high
sampl
throughput
lastli
rtpcr
reli
presenc
detect
sampl
collect
asymptomat
patient
infect
sinc
recov
pcr
would
identifi
prior
infect
control
measur
would
enforc
meanwhil
ct
system
expens
requir
technic
expertis
specif
diagnos
technolog
need
adapt
address
defici
accord
immedi
prioriti
diagnost
research
develop
nucleic
acid
protein
test
detect
longerterm
prioriti
integr
test
multiplex
panel
order
improv
surveil
effort
serolog
test
use
protein
need
addit
nucleic
acid
test
test
benefit
detect
recoveri
unlik
nucleic
acid
test
enabl
clinician
track
sick
recov
patient
provid
better
estim
total
infect
pointofcar
test
costeffect
handheld
devic
use
diagnos
patient
outsid
central
facil
oper
area
like
commun
center
reduc
burden
clinic
nucleic
acid
test
use
isotherm
amplif
current
develop
detect
isotherm
amplif
techniqu
conduct
singl
temperatur
need
special
laboratori
equip
provid
similar
analyt
sensit
techniqu
includ
recombinas
polymeras
amplif
helicasedepend
amplif
loopmedi
isotherm
amplif
lamp
sever
academ
laboratori
develop
clinic
test
revers
transcript
lamp
rtlamp
test
rtlamp
use
dna
polymeras
four
six
primer
bind
six
distinct
region
target
genom
fourprim
system
two
inner
primer
forward
revers
inner
primer
two
outer
primer
lamp
highli
specif
use
higher
number
lamp
diagnost
test
patient
sampl
ad
tube
amplifi
dna
detect
turbid
byproduct
reaction
color
addit
phsensit
dye
fluoresc
addit
fluoresc
dye
bind
doublestrand
dna
reaction
occur
h
analyt
limit
detect
copi
per
approach
simpl
oper
easi
visual
detect
less
background
signal
need
drawback
lamp
challeng
optim
primer
reaction
condit
isotherm
amplif
techniqu
detect
isotherm
amplif
techniqu
multiplex
amplif
andor
readout
stage
multiplex
use
polymer
bead
encod
uniqu
optic
signatur
eg
organ
fluoresc
molecul
barcod
barcod
design
differ
biomark
panel
detect
multipl
analyt
singl
patient
sampl
one
reaction
multiplex
increas
amount
inform
gain
singl
test
improv
clinic
sensit
one
way
encod
uniqu
signatur
agent
emit
fluoresc
signal
uniqu
emiss
code
captur
dna
antibodi
bead
surfac
posit
detect
occur
patient
sampl
contain
sequenc
antigen
link
bead
captur
molecul
secondari
probe
label
fluorophor
differ
emiss
bead
barcodedbead
multiplex
panel
diagnos
cystic
fibrosi
respiratori
barcodedbead
assayssystem
engin
laboratori
use
effort
underway
develop
pointofcar
howev
difficulti
lie
design
readout
devic
complex
barcod
signal
stem
organ
molecul
requir
uniqu
instrument
design
discern
code
research
work
overcom
limit
use
inorgan
quantum
dot
barcod
enabl
batteryoper
excit
smartphon
camera
captur
emiss
signal
kim
et
al
demonstr
clinic
specif
sensit
use
quantum
dot
barcod
diagnos
patient
hepat
b
isotherm
revers
polymeras
panel
barcod
formul
tablet
easi
dissemin
barcod
panel
design
respiratori
virus
coronavirus
sexual
transmit
diseas
andor
symptom
eg
fever
cough
diarrhea
addit
isotherm
amplif
nucleic
acid
test
could
use
detect
sherlock
detect
strategi
use
ribonucleas
rna
viral
rna
target
revers
transcrib
cdna
isotherm
amplifi
use
revers
polymeras
amplif
amplifi
product
transcrib
back
rna
complex
rna
guid
sequenc
bind
amplifi
rna
upon
target
bind
activ
cleav
surround
fluorophorequench
probe
produc
fluoresc
signal
compon
sherlock
freezedri
prior
studi
use
sherlock
could
detect
copiesml
clinic
serum
urin
isol
zika
sherlock
protocol
detect
anoth
detect
system
test
clinic
viral
protein
antigen
antibodi
creat
respons
infect
use
diagnos
chang
viral
load
cours
infect
may
make
viral
protein
difficult
detect
exampl
lung
et
al
show
high
salivari
viral
load
first
week
onset
symptom
gradual
declin
contrast
antibodi
gener
respons
viral
protein
may
provid
larger
window
time
indirectli
detect
antibodi
test
particularli
use
surveil
one
potenti
challeng
develop
accur
serolog
test
includ
potenti
crossreact
antibodi
antibodi
gener
coronavirus
lv
et
al
test
plasma
sampl
patient
protein
sarscov
saw
high
frequenc
current
serolog
test
ie
blood
test
specif
antibodi
zhang
et
al
detect
immunoglobulin
g
igg
igm
human
serum
patient
use
enzymelink
immunosorb
assay
elisa
use
nucleocapsid
protein
amino
acid
sequenc
homolog
sarsrel
virus
recombin
protein
adsorb
onto
surfac
plate
excess
protein
wash
away
dilut
human
serum
ad
h
plate
wash
antihuman
igg
function
horseradish
peroxidas
ad
allow
bind
target
plate
wash
follow
addit
substrat
peroxidas
react
substrat
caus
color
chang
detect
plate
reader
igg
present
sandwich
adsorb
nucleoprotein
antihuman
igg
probe
result
posit
signal
igm
test
zhang
et
al
similar
structur
use
antihuman
igm
adsorb
plate
nucleocapsid
probe
test
posit
patient
sampl
confirm
rtpcr
found
level
antibodi
increas
first
day
symptom
onset
day
zero
patient
posit
igm
igg
respect
increas
day
antibodi
detect
respiratori
blood
fecal
sampl
xiang
et
al
also
detect
igg
igm
antibodi
suspect
given
recent
studi
may
also
protein
cellular
marker
use
detect
guan
et
al
show
infect
patient
elev
level
creactiv
protein
ddimer
well
low
level
lymphocyt
leukocyt
blood
challeng
use
biomark
also
abnorm
ill
multiplex
test
antibodi
small
molecul
marker
could
improv
specif
pointofcar
test
use
diagnos
patient
without
send
sampl
central
facil
therebi
enabl
commun
without
laboratori
infrastructur
detect
infect
patient
later
flow
antigen
detect
one
pointofcar
approach
develop
diagnos
commerci
later
flow
assay
paperlik
membran
strip
coat
two
line
gold
nanoparticleantibodi
conjug
present
one
line
captur
antibodi
patient
sampl
eg
blood
urin
deposit
membran
protein
drawn
across
strip
capillari
action
pass
first
line
antigen
bind
gold
nanoparticleantibodi
conjug
complex
flow
togeth
membran
reach
second
line
complex
immobil
captur
antibodi
red
blue
line
becom
visibl
individu
gold
nanoparticl
red
color
solut
contain
cluster
gold
nanoparticl
blue
due
coupl
plasmon
band
later
flow
assay
demonstr
clinic
sensit
specif
accuraci
igm
igg
respect
test
detect
igm
igg
yield
clinic
sensit
nucleic
acid
test
also
incorpor
later
flow
assay
previous
rtlamp
test
combin
later
flow
readout
detect
test
singl
use
suffer
poor
analyt
sensit
comparison
rtpcr
improv
assay
readout
signal
research
develop
varieti
signal
amplifi
techniqu
eg
thermal
imag
assembl
multipl
gold
nanoparticl
anoth
approach
use
pointofcar
microfluid
devic
devic
consist
palmsiz
chip
etch
micrometers
channel
reaction
chamber
chip
mix
separ
liquid
sampl
use
electrokinet
capillari
vacuum
andor
forc
chip
construct
materi
polydimethyl
sulfoxid
glass
paper
key
advantag
use
microfluid
includ
miniatur
small
sampl
volum
rapid
detect
time
laksanasopin
et
al
develop
microfluidicsbas
smartphon
attach
detect
antibodi
three
sexual
transmit
infect
sequenti
move
reagent
prestor
cassett
platform
show
clinic
sensit
specif
hiv
respect
test
patient
technolog
adapt
detect
rna
protein
describ
diagnost
technolog
shown
clinic
feasibl
tabl
provid
extens
list
emerg
technolog
adapt
detect
mani
platform
develop
academ
laboratori
electrochem
sensor
paperbas
system
surfaceenhanc
raman
scatter
base
system
approach
earli
stage
develop
use
diagnos
immedi
one
delin
diagnost
technolog
develop
four
phase
figur
phase
refer
technolog
proofofconcept
stage
research
use
synthet
target
valid
concept
phase
refer
technolog
analyz
small
number
patient
sampl
ie
sampl
phase
typic
refer
technolog
advanc
clinic
trial
larg
patient
cohort
phase
technolog
commerci
use
patient
emerg
technolog
could
play
role
detect
futur
outbreak
control
epidem
requir
extens
surveil
share
epidemiolog
data
patient
healthcar
entiti
local
hospit
requir
tool
improv
speed
eas
commun
manag
spread
diseas
smartphon
leverag
purpos
possess
connect
comput
power
hardwar
facilit
electron
report
epidemiolog
databas
pointofcar
test
figur
exponenti
rise
worldwid
smartphon
adopt
includ
subsaharan
africa
make
smartphon
wide
access
technolog
coordin
respons
larg
outbreak
like
global
spread
catalyz
insuffici
commun
notabl
exampl
iran
confirm
first
case
februari
case
fatal
rate
death
export
case
iranian
origin
report
transmiss
model
suggest
number
infect
individu
iran
smartphon
pair
preexist
diagnost
test
provid
realtim
geospati
inform
empow
nation
global
health
agenc
implement
coordin
control
strategi
sever
research
group
use
smartphon
geospati
track
infecti
diseas
hiv
ebola
ebola
smartphon
use
contact
trace
practic
track
identifi
peopl
come
contact
infect
patient
may
also
smartphon
digit
process
contact
trace
provid
complet
shareabl
record
without
commun
region
healthcar
agenc
transmiss
rate
vari
across
occur
sar
outbreak
canada
toronto
ontario
case
import
wherea
vancouv
british
columbia
case
time
ontario
provinci
public
health
agenc
british
columbia
agenc
previous
identifi
provinc
risk
import
emerg
infecti
diseas
prior
sar
outbreak
british
columbia
public
health
agenc
establish
digit
network
facilit
commun
across
commun
network
expand
leverag
smartphon
connect
smartphon
use
field
upload
share
epidemiolog
data
onto
public
health
databas
coordin
outbreak
respons
peopl
suspect
encount
commun
barrier
healthcar
provid
anyon
exhibit
mild
respiratori
symptom
may
hesit
travel
overcrowd
hospit
face
increas
risk
contract
smartphon
leverag
provid
direct
line
commun
patient
clinician
without
risk
infect
either
parti
influenza
pandem
switzerland
use
medic
teleconsult
manag
suspect
case
addit
exist
report
teleconsult
led
higher
total
report
influenza
compar
inperson
consult
due
lower
barrier
access
infect
individu
visit
hospit
test
posit
patient
mild
symptom
sent
home
selfquarantin
natur
deter
commun
patient
clinician
result
advers
mental
health
effect
patient
reduc
monitor
clinician
smartphon
app
connect
patient
mental
health
counselor
cope
isol
fear
diseas
outbreak
addit
patient
selfreport
symptom
behavior
facilit
remot
monitor
smartphonebas
report
also
provid
epidemiologist
inform
relev
potenti
transmiss
mechan
exampl
mer
outbreak
smartphon
app
use
monitor
travel
hajj
pilgrimag
app
user
report
hand
hygien
protocol
anim
contact
onset
symptom
pilgrimag
return
home
similar
app
use
keep
public
health
agenc
activ
inform
improv
respons
diseas
outbreak
recent
year
signific
develop
integr
smartphon
diagnost
technolog
smartphon
compon
eg
camera
flashlight
audio
jack
use
readout
diagnost
assay
place
convent
laboratori
devic
simplifi
diagnost
workflow
autom
readout
databas
exampl
smartphonebas
microscop
field
test
cameroon
demonstr
faster
turnaround
time
standard
kanazawa
et
al
valid
use
smartphon
accompani
forward
look
infrar
radar
flir
thermal
detect
bodi
temperatur
due
inflamm
technolog
may
also
adapt
detect
fever
common
symptom
mani
coronavirus
includ
mudanyali
et
al
also
develop
smartphonebas
microscop
transfer
diagnost
result
databas
analysi
spatiotempor
devic
help
address
need
pointofcar
test
commun
level
underreport
avail
establish
diagnost
technolog
phase
figur
enabl
research
plugandplay
design
diagnost
technolog
took
decad
optim
play
import
role
identifi
manag
spread
lesson
learn
sar
outbreak
guid
develop
identif
detect
transmiss
electron
microscopi
use
identifi
morpholog
viru
genom
sequenc
use
confirm
ident
viru
sequenc
data
use
help
design
pcr
primer
probe
sarscov
took
month
identifi
techniqu
use
identifi
rapid
identif
sequenc
enabl
rapid
develop
nucleic
acid
test
approach
provid
first
line
defens
outbreak
next
step
work
establish
serolog
test
easier
administ
may
complement
nucleic
acid
test
diagnos
infect
call
develop
pointofcar
test
multiplex
assay
technolog
straddl
phase
figur
isotherm
amplif
barcod
microfluid
technolog
develop
becom
plugandplay
system
rapidli
implement
outbreak
situat
combin
diagnost
smartphon
provid
greater
commun
surveil
conclus
diagnost
import
part
toolbox
deal
outbreak
enabl
healthcar
worker
direct
resourc
effort
patient
process
curb
spread
infecti
pathogen
reduc
mortal
note
data
evolv
quickli
specif
review
may
chang
studi
becom
avail
mani
highlight
studi
also
identifi
weak
experiment
studi
design
referenc
manuscript
preprint
peerreview
